MYND Life Sciences Inc.

Home
Canada
Vancouver, BC
MYND Life Sciences Inc.

MYND Life Sciences Inc. is a leading life sciences company focused on improving mental health.

05/08/2022

End the Stigma “I held concerns about being branded a ‘bad mother’ for requiring medication.”

Many women suffer in silence, dismissing their struggles as a normal part of pregnancy and childbirth and failing to seek care. Early detection during pregnancy is essential for effective treatment post-delivery. Greater awareness and understanding can lead to better outcomes for women and their babies.

We are designing a Biomarker that potentially could early identify PPD.

Crisis no longer needs to be the diagnosis.

CSE: MYND / OTC: MYNDF

03/16/2022

MYND Life Sciences Executes a Non-Binding MOU with Tidal Psychedelics.

MYND is pleased to announce it has entered into a non-binding memorandum of understanding ("MOU") to acquire all the issued and outstanding shares of Tidal Care Inc. o/a Tidal Psychedelics ("Tidal").

Tidal is a vertically integrated psilocybin company with access to a $10 million leasehold facility purpose-built for cannabis and mycelium cultivation. The proposed collaboration is a strategic fit for both organizations; key management personnel from Tidal will bolster MYND's executive team with established leadership in successfully structuring and growing private and public corporations across several industries, while existing Tidal shareholders gain access to four (4) global provisional patents, public stock market liquidity, access to a new $2.5 million cannabis-specific building and a $1.2 million investment into the Company's research and development. The primary goal of the combined entity is to provide MYND's highly sophisticated intellectual property portfolio with access to additional capital, and a diverse and experienced management team to advance the Company's research and development initiatives.

03/07/2022

Mynd's proprietary biomarkers (which are naturally occurring compounds in the body's bloodstream) will target and monitor levels of inflammation, allowing for an early diagnosis and ultimately a higher chance of disease prevention.

Soon you will be able to monitor your inflammation body index from home with a drop of blood.

02/28/2022

We Remember Their Love When They No Longer Do. What if we told you we could diagnose early-onset dementia sooner and more accurately?

Address

Vancouver, BC

Website

http://myndsciences.com/

Alerts

Be the first to know and let us send you an email when MYND Life Sciences Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.